Brittany Bradrick serves as Executive at Dermata Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Brittany Bradrick has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 31, 2023 involved selling 27,380 shares valued at $0.
Brittany Bradrick currently holds 23,443 shares of Dermata Therapeutics, Inc. (DRMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brittany Bradrick has been a net neutral trader of DRMA stock. They have purchased $0 and sold $0 worth of shares.
Brittany Bradrick's most recent insider trade was on Jul 31, 2023, when they sold 27,380 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 31, 2022 | SPPI | $0 | Award | 27,380 | $N/A | Discretionary |
| Jul 7, 2022 | DRMA | $0 | Award | 8,602 | $N/A | Discretionary |
| Apr 7, 2022 | DRMA | $0 | Award | 5,031 | $N/A | Discretionary |